Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World - Image 1

£83.00

Edward Elgar Publishing Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Name: Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World
Brand: Edward Elgar Publishing
Price: 70.48 GBP
Availability: InStock

Law

Price History & Forecast

Last 79 days • 79 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 79 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £70 (64 days, 81.0%)

Price range: £70 - £83

Price levels: 2 different prices over 79 days

Description

Product Description Boosting Pharmaceutical Innovation In The Post-Trips Era investigates the concept of innovation and illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation. Drawing on extensive country and company case studies, it identifies the key issues relevant to the revival of local pharmaceutical industries. Based on an understanding of the post-TRIPS environment and case studies of national innovation strategies, the book specifically addresses an important question to what extent can lessons from national experiences be transferred to current policy developments for innovation in the pharmaceutical industry in a developing country context? The book sets out a number of recommendations on how this can be achieved. It suggests that it can be done in relation to the key development objectives of promoting the technological and scientific advancement of the country, enhancing local pharmaceutical innovation capacities, adapting patent law to own local realities, providing wide access to medicines and knowledge, safeguarding public health interests, and fostering innovation. Practitioners and policy planners within the pharmaceutical industry will deem this book invaluable as it addresses a number of practical implications for the promotion of the pharmaceutical industry. It will also be of enormous interest to students, researchers and academics specialising in intellectual property law and policy, science and technology, and the management of technology and innovation. Review ‘Overall, the book is very readable and well written, and it is clearly an interesting addition to the existing literature on pharmaceutical innovation in developing world.’ -- European Intellectual Property Review About the Author Burcu Kiliç, Public Citizen’s Global Access to Medicines Program

Product Specifications

Brand: Edward Elgar Publishing
Format: hardcover
ASIN: 1782544127
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 25 July 2014
Listed Since: 20 February 2014

Barcode

No barcode data available

Edward Elgar Publishing Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Global Issues in Pharmaceutical Marketing

A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Drug Control and International Law (Routledge Research in International Law)

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

The Public Financing of Pharmaceuticals: An Economic Approach

Global Pharmaceutical Policy

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

Drug Information: A Guide for Pharmacists, Fourth Edition

Converging Pharmacy Science and Engineering in Computational Drug Discovery (Advances in Healthcare Information Systems and Administration)

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Integrated Pharmaceutics: Applied Preformulation, Product Design, and Regulatory Science

Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Write It Down: Guidance for Preparing Effective and Compliant Documentation

Pharmaceutical Care in Digital Revolution: Blending Digital with Human Innovation

Solid State Development and Processing of Pharmaceutical Molecules: Salts, Cocrystals, and Polymorphism (Methods & Principles in Medicinal Chemistry)

Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Optimization of Pharmaceutical Processes: 189 (Springer Optimization and Its Applications, 189)

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs